biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Mar 01, 2016 8:48pm

145 Views

Post# 24611256

RE:RE:Shares for Services

Jkj, I don't know who got the 150k shares or what they are doing. So hard to say. Most of the buying today was through ITG. They were mentioned with the large volume buying last week as well on the 24th, the day after the Neuroscience BioPartnering and Investment Forum. So if I had to guess, I'd say today is perhaps a continuation of that US interest in us, same or different folks.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!